Metraipolis › archive › dc_8df38cb70de3

Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives — Europe PMC PMID:42192911

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42192911
DOI
10.3390/cancers18101551
License (as archived)
solo-consultazione
Archived
2026-11-02T12:11:54.254Z
SHA-256 of the archived text
2b14e05f92a02ea855442631f49eac57a1f73a65d0882b0f3ea48052e196a516
Stable URL of this page
https://metraipolis.com/documento/dc_8df38cb70de3

How to cite

Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives — Europe PMC PMID:42192911 — Europe PMC (en), https://europepmc.org/article/MED/42192911 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8df38cb70de3 (Metraipolis archive dc_8df38cb70de3, sha256 2b14e05f92a02ea855442631f49eac57a1f73a65d0882b0f3ea48052e196a516)
BibTeX
@misc{dc8df38cb70de3,
  title = {Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives — Europe PMC PMID:42192911},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42192911},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8df38cb70de3; sha256 2b14e05f92a02ea855442631f49eac57a1f73a65d0882b0f3ea48052e196a516},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192911. Agents can read the archived copy with the MCP tool read_document.